(Date:12/2/2009)...other foods have done more than raise public aware...quietly fueling a boom in the market for food test...tions. That,s the topic of the two-part cover stor...News , (C&EN) ACS, weekly newsmagazine. , C&EN A...ondent Marc Reisch point out that food safety is a...
(Date:12/2/2009)... you, at least if you are a mammal cell. , Resea...ogy Center have shown that in healthy cells, a bun...nucleus, its genetic storehouse, in its proper pla... nuclear shape, the researchers say, could provide...such as cancer, muscular dystrophy and the age-acc...
(Date:12/2/2009)... PALM HARBOR, Fla., Dec. 2 /PRNewswire-FirstCall/ ...(OTC Bulletin Board: CICI), a leading supplier of ...s automation in the financial industry* and the re...ion and Docubase Systems Inc. ("Docubase"), a lead...EDM) software provider announced today that they h...
Breaking Biology News(10 mins):A cell's 'cap' of bundled fibers could yield clues to disease 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4Keep Oral Health in Check This School Year With the New Philips Sonicare for Kids Power Toothbrush 55519 1Keep Oral Health in Check This School Year With the New Philips Sonicare for Kids Power Toothbrush 55519 2Keep Oral Health in Check This School Year With the New Philips Sonicare for Kids Power Toothbrush 55519 3Sagent Pharmaceuticals Announces Launch of Fluconazole Injection in Premix Ready to Use IV Bags 55516 1Sagent Pharmaceuticals Announces Launch of Fluconazole Injection in Premix Ready to Use IV Bags 55516 2ANAVEX reports sigma receptor review published in leading journal 55513 1ANAVEX reports sigma receptor review published in leading journal 55513 2ANAVEX reports sigma receptor review published in leading journal 55513 3(Date:12/3/2009)...PRNewswire/ -- Nikon Corporation, an innovator of ... it has signed a licensing agreement with Harvard ...ochastic Optical Reconstruction Microscopy (STORM)...on will manufacture STORM enabled microscopy syste...ikon Corporation President, Mr. Michio Kariya, and...
(Date:12/3/2009)...PRNewswire-FirstCall/ -- Inverness Medical Innovat...ling individuals to take charge of their health at...health management, has declared a dividend of $3.0...Preferred Stock ( IMA-PB). The dividend will be pa...are equal to the quotient of (a) $3.00 divided by ...
(Date:12/2/2009)...RNewswire/ -- Reportlinker.com announces that a ne...ogue: ,, Neurostimulation - A Global Market Pe...4232/Neurostimulation---A-Global-Market-Perspectiv...tands enthused by the growing base of aging popula...es such as, Parkinson,s, and Alzheimer,s disease. ...
(Date:12/2/2009)... Peregrine Pharmaceutica...n of patient enrollment in a dose confirmation and...relapsed glioblastoma multiforme (GBM), the deadli...noclonal antibody linked to a radioisotope being d...tara specifically targets cells at the center of b...
Breaking Biology Technology:Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5...inancial times, good relationships with shareholde...itive relationship with current investors is espec...he best source for leading a companys next round o...t: , , Treat investors like customers! Understan...rtant in meeting their expectations. It is as impo...
...s of start-up and early-stage companies , ,In an...eadership, set business goals and prioritize steps...arly-stage companies, those activities must be acc...s their full, unwavering attention. Capital must b...erved. A business owner has to concentrate on deve...
...he University of Wisconsin-Stevens Point will rece...The WiSys Technology Foundation , an organization...Madison, has received notice from the U.S. Patent ... for a UW-Stevens Points (UWSP) associate professo...ssor of soils in UWSP s College of Natural Resour...
Other Biology Technology:Enhancing Relationships with Investors 2Management Perspectives: Outsource HR 2Management Perspectives: Outsource HR 3UW-Stevens Point Professor Receives Patent Approval For New Technology 2Acridinium Quench Solution from Cayman Chemical
Mouse Anti-C3a / C3a des Arg Monoclonal Antibody, Unconjugated, Clone 2991 from Abcam
Rabbit Anti-NMDAR1 C2' Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-PI3K p110 delta (Poly6049) Polyclonal Antibody, Unconjugated from BioLegend
Biology Products: